Article
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia
26 May 2010
Abstract excerpt
BACKGROUND: Fludarabine, is one of the most active single agents in the treatment of chronic lymphocytic leukemia (CLL). Over time, however, virtually all CLL patients become fludarabine-refractory. To elucidate whether microRNAs are involved in the development of fludarabine resistance, we analyzed the expression of 723 human miRNAs before and 5-days after fludarabine mono-therapy in 17 CLL patients which were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
